{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:57:12Z","timestamp":1787241432318,"version":"build-2736575974"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Physiol Biochem"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s13105-024-01040-z","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:02:05Z","timestamp":1723680125000},"page":"757-774","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Physiological and metabolic functions of the \u03b23-adrenergic receptor and an approach to therapeutic achievements"],"prefix":"10.1007","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6741-699X","authenticated-orcid":false,"given":"Saptadip","family":"Samanta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debasis","family":"Bagchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manashi","family":"Bagchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,15]]},"reference":[{"key":"1040_CR1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1677\/joe.0.1390479","volume":"139","author":"H Abe","year":"1993","unstructured":"Abe H, Minokoshi Y, Shimazu T (1993) Effect of a \u03b23-adrenergic agonist, BRL35135A, on glucose uptake in rat skeletal muscle in vivo and in vitro. J Endocrinol 139:479\u2013486","journal-title":"J Endocrinol"},{"issue":"1","key":"1040_CR2","doi-asserted-by":"publisher","first-page":"7646","DOI":"10.1038\/s41598-017-07898-y","volume":"7","author":"N Aizawa","year":"2017","unstructured":"Aizawa N, Ichihara K, Fukuhara H, Fujimura T, Andersson KE, Homma Y et al (2017) Characteristics of the mechanosensitive bladder afferent activities in relation with microcontractions in male rats with bladder outlet obstruction. Sci Rep 7(1):7646. https:\/\/doi.org\/10.1038\/s41598-017-07898-y. PMID 28794457","journal-title":"Sci Rep"},{"key":"1040_CR3","doi-asserted-by":"publisher","unstructured":"Arch JR, Ainsworth AT, Cawthorne MA, Piercy V, Sennitt MV, Thody VE et al (1984) \u03b2-adrenoceptor on brown adipocytes as target for\u03b2Atypical antiobesity drugs. Nature 309(5964): 163-5. https:\/\/doi.org\/10.1038\/309163a0. PMID 6325935","DOI":"10.1038\/309163a0"},{"key":"1040_CR4","doi-asserted-by":"publisher","unstructured":"Arch JR (1989) \u03b2-adrenoceptor\u03b2The brown adipocyte. Proc Nutr Soc. 48(2): 215\u2009\u2013\u200923. https:\/\/doi.org\/10.1079\/pns19890032. PMID 2552450","DOI":"10.1079\/pns19890032"},{"key":"1040_CR5","unstructured":"Arch JRS, Ainsworth AT, Ellis RDM, Piercy V, Thody VE, Thurlby PL et al (1984) Treatment of obesity with thermogenic \u03b2-adrenoceptor agonists: studies on BRL 26830A in rodents. Int J Obes 8;Suppl 1: 1\u201311. PMID 6152555."},{"key":"1040_CR6","doi-asserted-by":"publisher","unstructured":"Arch JRS, Kaumann AJ (1993) \u03b23 and atypical \u03b2-adrenoceptors. Med Res Rev. 13(6): 663\u2013729. https:\/\/doi.org\/10.1002\/med.2610130604. PMID 8258999","DOI":"10.1002\/med.2610130604"},{"issue":"14","key":"1040_CR7","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1111\/bph.14635","volume":"176","author":"E Arioglu-Inan","year":"2019","unstructured":"Arioglu-Inan E, Kayki-Mutlu G, Michel MC (2019) Cardiac \u03b23 -adrenoceptors-A role in human pathophysiology? Br J Pharmacol 176(14):2482\u20132495. https:\/\/doi.org\/10.1111\/bph.14635. PMID 30801686, PMCID PMC6592859","journal-title":"Br J Pharmacol"},{"key":"1040_CR8","doi-asserted-by":"publisher","unstructured":"Arner P, Andersson DP, B\u00e4ckdahl J, Dahlman I, Ryd\u00e9n M (2018) Weight gain and impaired glucose metabolism in women are predicted by inefficient subcutaneous fat cell lipolysis. Cell Metab. 28(1): 45\u201354.e3. https:\/\/doi.org\/10.1016\/j.cmet.2018.05.004. PMID 29861390","DOI":"10.1016\/j.cmet.2018.05.004"},{"issue":"10","key":"1040_CR9","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.2337\/db18-0462","volume":"67","author":"AS Baskin","year":"2018","unstructured":"Baskin AS et al (2018) Regulation of human adipose tissue activation, gallbladder size, and bile acid metabolism by a \u03b23-adrenergic receptor agonist. Diabetes 67(10):2113\u20132125","journal-title":"Diabetes"},{"issue":"7","key":"1040_CR10","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.2337\/db15-0146","volume":"64","author":"MJ Betz","year":"2015","unstructured":"Betz MJ (2015) Enerb\u00e4ck S. Human brown adipose tissue: what we have learned so far. Diabetes 64(7):2352\u20132360. https:\/\/doi.org\/10.2337\/db15-0146. PMID 26050667","journal-title":"Diabetes"},{"key":"1040_CR11","doi-asserted-by":"publisher","first-page":"100674","DOI":"10.1016\/j.curtheres.2022.100674","volume":"96","author":"BM Brucker","year":"2022","unstructured":"Brucker BM, King J, Mudd PN Jr, McHale K (2022) Selectivity and maximum response of vibegron and mirabegron for \u03b23-adrenergic receptors. Curr Ther Res Clin Exp 96:100674","journal-title":"Curr Ther Res Clin Exp"},{"issue":"7","key":"1040_CR12","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1161\/CIRCHEARTFAILURE.121.00912","volume":"15","author":"H Bundgaard","year":"2022","unstructured":"Bundgaard H, Raja AA, Iversen K, Valeur N et al (2022) Hemodynamic effects of cyclic guanosine monophosphate-dependent signaling through \u03b23 adrenoceptor stimulation in patients with advanced heart failure: a randomized invasive clinical trial. Ciculation: Heart Faliure 15(7):651\u2013666. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.121.00912","journal-title":"Ciculation: Heart Faliure"},{"key":"1040_CR13","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/ejhf.714","volume":"19","author":"H Bundgaard","year":"2017","unstructured":"Bundgaard H, Axelsson A, Hartvig Thomsen J, S\u00f8rgaard M, Kofoed Klaus F, Hasselbalch R, Rasmussen HH (2017) The first-inman randomized trial of a \u03b23 adrenoceptor agonist in chronic heart failure: the BEAT\u2010HF trial. Eur J Heart Fail 19:566\u2013575","journal-title":"Eur J Heart Fail"},{"key":"1040_CR14","doi-asserted-by":"publisher","unstructured":"Burkey BF, Dong M, Gagen K, Eckhardt M, Dragonas N, Chen W et al (2000) Effects of pioglitazone on promoting energy storage, not expenditure, in brown adipose tissue of obese fa\/fa Zucker rats: comparison to CL 316,243. Metabolism. 49(10): 1301-8. https:\/\/doi.org\/10.1053\/meta.2000.9524. PMID 11079820","DOI":"10.1053\/meta.2000.9524"},{"issue":"2","key":"1040_CR15","first-page":"121","volume":"46","author":"DB Bylund","year":"1994","unstructured":"Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP et al (1994) International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46(2):121\u2013136. PMID 7938162","journal-title":"Pharmacol Rev"},{"issue":"1","key":"1040_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1152\/physrev.00015.2003","volume":"84","author":"B Cannon","year":"2004","unstructured":"Cannon B, Nedergaard J (2004) Brown adipose tissue: function and physiological significance. Physiol Rev 84(1):277\u2013359. https:\/\/doi.org\/10.1152\/physrev.00015.2003. PMID 14715917","journal-title":"Physiol Rev"},{"key":"1040_CR17","doi-asserted-by":"publisher","unstructured":"Cao W, Medvedev AV, Daniel KW, Collins S (2001) beta-Adrenergic activation of p38 MAP kinase in adipocytes: cAMP induction of the uncoupling protein 1 (UCP1) gene requires p38 MAP kinase. J Biol Chem. 276(29): 27077-82. https:\/\/doi.org\/10.1074\/jbc.M101049200. PMID 11369767","DOI":"10.1074\/jbc.M101049200"},{"key":"1040_CR18","doi-asserted-by":"publisher","unstructured":"Carmen GY, V\u00edctor SM (2006) Signalling mechanisms regulating lipolysis. Cell Signal. 18(4): 401-8. https:\/\/doi.org\/10.1016\/j.cellsig.2005.08.009. PMID 16182514","DOI":"10.1016\/j.cellsig.2005.08.009"},{"key":"1040_CR19","doi-asserted-by":"publisher","unstructured":"Chamberlain PD, Jennings KH, Paul F, Cordell J, Berry A, Holmes SD et al (1999) The tissue distribution of the human beta3-adrenoceptor studied using a monoclonal antibody: direct evidence of the beta3-adrenoceptor in human adipose tissue, atrium and skeletal muscle. Int J Obes Relat Metab Disord.;23(10):1057-65. https:\/\/doi.org\/10.1038\/sj.ijo.0801039. PMID 10557026","DOI":"10.1038\/sj.ijo.0801039"},{"key":"1040_CR20","doi-asserted-by":"publisher","unstructured":"Chapple CR, Cardozo L, Nitti VW, Siddiqui E, Michel MC (2014) Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability. Neurourol Urodyn. 33(1): 17\u201330. https:\/\/doi.org\/10.1002\/nau.22505. PMID 24127366","DOI":"10.1002\/nau.22505"},{"key":"1040_CR21","doi-asserted-by":"publisher","unstructured":"Chiang SH, Bazuine M, Lumeng CN, Geletka LM, Mowers J, White NM et al (2009) The protein kinase IKKepsilon regulates energy balance in obese mice. Cell. 138(5): 961\u2009\u2013\u200975. https:\/\/doi.org\/10.1016\/j.cell.2009.06.046. PMID 19737522, PMCID PMC2756060","DOI":"10.1016\/j.cell.2009.06.046"},{"issue":"6","key":"1040_CR22","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1017\/S0007114515000100","volume":"113","author":"MS Choi","year":"2015","unstructured":"Choi MS, Kim YJ, Kwon EY, Ryoo JY, Kim SR, Jung UJ (2015) High-fat diet decreases energy expenditure and expression of genes controlling lipid metabolism, mitochondrial function and skeletal system development in the adipose tissue, along with increased expression of extracellular matrix remodelling- and inflammation-related genes. Br J Nutr 113(6):867\u2013877. https:\/\/doi.org\/10.1017\/S0007114515000100. PMID 25744306","journal-title":"Br J Nutr"},{"key":"1040_CR23","doi-asserted-by":"publisher","unstructured":"Clookey SL, Welly RJ, Shay D, Woodford ML, Fritsche KL, Rector RS et al (2019) Beta 3 adrenergic receptor activation rescues metabolic dysfunction in female estrogen receptor alpha-null mice. Front Physiol. 10:9. https:\/\/doi.org\/10.3389\/fphys.2019.00009. PMID 30804793","DOI":"10.3389\/fphys.2019.00009"},{"key":"1040_CR24","doi-asserted-by":"publisher","unstructured":"Coelho A, Antunes-Lopes T, Gillespie J, Cruz F (2017) \u03b2-3 adrenergic receptor is expressed in acetylcholine-containing nerve fibers of the human urinary bladder: an immunohistochemical study. Neurourol Urodyn. 36(8): 1972-80. https:\/\/doi.org\/10.1002\/nau.23224. PMID 28185314","DOI":"10.1002\/nau.23224"},{"key":"1040_CR25","doi-asserted-by":"publisher","unstructured":"Cohen P, Levy JD, Zhang Y, Frontini A, Kolodin DP, Svensson KJ et al (2014) Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch. Cell. 156(1\u20132): 304\u2009\u2013\u200916. https:\/\/doi.org\/10.1016\/j.cell.2013.12.021. PMID 24439384","DOI":"10.1016\/j.cell.2013.12.021"},{"issue":"1","key":"1040_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cmet.2014.12.009","volume":"21","author":"AM Cypess","year":"2015","unstructured":"Cypess AM et al (2015) Activation of human brown adipose tissue by a \u03b23-adrenergic receptor agonist. Cell Metab 21(1):33\u201338","journal-title":"Cell Metab"},{"key":"1040_CR27","doi-asserted-by":"publisher","first-page":"6897","DOI":"10.3390\/jcm12216897","volume":"12","author":"AM Da Browska","year":"2023","unstructured":"Da Browska AM, Dudka J (2023) Mirabegron, a selective \u03b23-adrenergic receptor agonist, as a potential anti-obesity drug. J Clin Med 12:6897. https:\/\/doi.org\/10.3390\/jcm12216897","journal-title":"J Clin Med"},{"key":"1040_CR28","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1038\/sj.ijo.0802148","volume":"26","author":"R De Matteis","year":"2002","unstructured":"De Matteis R, Arch JR, Petroni ML, Ferrari D, Cinti S, Stock MJ (2002) Immunohistochemical identification of the \u03b23-adrenoceptor in intact human adipocytes and ventricular myocardium: Effect of obesity and treatment with ephedrine and caneine. Int J Obes Relat Metab Disord 26:1442\u20131450","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"14","key":"1040_CR29","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.2174\/1381612013397339","volume":"7","author":"CJ de Souza","year":"2001","unstructured":"de Souza CJ, Burkey BF (2001) Beta3-adrenoceptor agonists as antidiabetic and antiobesity drugs in humans. Curr Pharm Des 7(14):1433\u20131449. https:\/\/doi.org\/10.2174\/1381612013397339. PMID 11472270","journal-title":"Curr Pharm Des"},{"key":"1040_CR30","doi-asserted-by":"publisher","unstructured":"Dixon TM, Daniel KW, Farmer SR, Collins S (2001) CCAAT\/enhancer-binding protein alpha is required for transcription of the beta 3-adrenergic receptor gene during adipogenesis. J Biol Chem. 276(1): 722-8. https:\/\/doi.org\/10.1074\/jbc.M008440200. PMID 11024036","DOI":"10.1074\/jbc.M008440200"},{"key":"1040_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/BF03174071","volume":"62","author":"C Duffaut","year":"2006","unstructured":"Duffaut C, Bour S, Pr\u00e9vot D, Marti L, Testar X, Zorzano A, Carp\u00e9n\u00e9 C (2006) Prolonged treatment with the beta3-adrenergic agonist CL 316243 induces adipose tissue remodeling in rat but not in guinea pig: 2) modulation of glucose uptake and monoamine oxidase activity. J Physiol Biochem 62:101\u2013111","journal-title":"J Physiol Biochem"},{"key":"1040_CR32","doi-asserted-by":"publisher","unstructured":"Dwaib HS, Michel MC (2023) Is the \u03b23-adrenoceptor a valid target for the treatment of obesity and\/or type 2 diabetes? Biomolecules. 13:1714. https:\/\/doi.org\/10.3390\/biom13121714","DOI":"10.3390\/biom13121714"},{"key":"1040_CR33","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1126\/science.2570461","volume":"245","author":"LJ Emorine","year":"1989","unstructured":"Emorine LJ, Marullo S, Briend-Sutren MM, Patey G, Tate K, Delauvier-Klutchko C, Strosberg D (1989) Molecular characterization of the human \u03b23-adrenergic receptor. Science 245:1118\u20131121","journal-title":"Science"},{"issue":"1","key":"1040_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0165-6147(94)90118-x","volume":"15","author":"LJ Emorine","year":"1994","unstructured":"Emorine LJ, Blin N, Strosberg AD (1994) The human \u03b23-adrenoceptor: the search for a physiological function. Trends Pharmacol Sci 15(1):3\u20137. https:\/\/doi.org\/10.1016\/0165-6147(94)90118-x. PMID 8140656","journal-title":"Trends Pharmacol Sci"},{"key":"1040_CR35","doi-asserted-by":"crossref","unstructured":"Ferrer-Lorente R, Cabot C, Fernandez Lopez LA, Alemanz M (2005) Combined effects of oleoyl-estrone and beta 3 adrenergic agonist (CL316,243) on lipid stores of diet induced overweight male Wistar rats. Life Sci. 2051-8","DOI":"10.1016\/j.lfs.2005.04.008"},{"issue":"22","key":"1040_CR36","doi-asserted-by":"publisher","first-page":"15909","DOI":"10.1016\/S0021","volume":"267","author":"B F\u00e8ve","year":"1992","unstructured":"F\u00e8ve B, Baude B, Krief S, Strosberg AD, Pairault J, Emorine LJ (1992) Dexamethasone down-regulates \u03b23-adrenergic receptors in 3T3-F442A adipocytes. J Biol Chem 267(22):15909\u201315915. https:\/\/doi.org\/10.1016\/S0021-9258(19)49620-8. PMID 1379241","journal-title":"J Biol Chem"},{"key":"1040_CR37","doi-asserted-by":"publisher","unstructured":"F\u00e8ve B, Elhadri K, Quignard-Boulang\u00e9 A, Pairault J (1994) Transcriptional down-regulation by insulin of the \u03b23-adrenergic receptor expression in 3T3-F442A adipocytes: a novel mechanism for repressing the cAMP signalling pathway. Proc Natl Acad Sci U S A. 91(12): 5677-81. https:\/\/doi.org\/10.1073\/pnas.91.12.5677. PMID 8202547","DOI":"10.1073\/pnas.91.12.5677"},{"issue":"5","key":"1040_CR38","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1172\/JCI134892","volume":"130","author":"BS Finlin","year":"2020","unstructured":"Finlin BS, Memetimin H, Zhu B, Confides AL, Vekaria HJ, El Khouli RH et al (2020) The \u03b23-adrenergic receptor agonist mirabegron improves glucose homeostasis in obese humans. J Clin Invest 130(5):2319\u20132331. https:\/\/doi.org\/10.1172\/JCI134892. PMID 31961829","journal-title":"J Clin Invest"},{"issue":"11","key":"1040_CR39","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1172\/JCI2496","volume":"101","author":"MH Fisher","year":"1998","unstructured":"Fisher MH, Amend AM, Bach TJ, Barker JM, Brady EJ, Candelore MR et al (1998) A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys. J Clin Invest 101(11):2387\u20132393. https:\/\/doi.org\/10.1172\/JCI2496. PMID 9616210","journal-title":"J Clin Invest"},{"key":"1040_CR40","doi-asserted-by":"publisher","unstructured":"Frontini A, Cinti S (2010) Distribution and development of brown adipocytes in the murine and human adipose organ. Cell Metab. 11(4): 253\u20136. https:\/\/doi.org\/10.1016\/j.cmet.2010.03.004. PMID 20374956","DOI":"10.1016\/j.cmet.2010.03.004"},{"key":"1040_CR41","doi-asserted-by":"publisher","unstructured":"Fu L, Isobe K, Zeng Q, Suzukawa K, Takekoshi K, Kawakami Y (2008) The effects of beta(3)-adrenoceptor agonist CL-316,243 on adiponectin, adiponectin receptors and tumor necrosis factor-alpha expressions in adipose tissues of obese diabetic KKAy mice. Eur J Pharmacol. 584(1):202\u20136. https:\/\/doi.org\/10.1016\/j.ejphar.2008.01.028. PMID 18304529","DOI":"10.1016\/j.ejphar.2008.01.028"},{"issue":"1","key":"1040_CR42","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jacbts.2020.01.009","volume":"5","author":"I Garcia-Lunar","year":"2020","unstructured":"Garcia-Lunar I, Blanco I, Fern\u00e1ndez-Friera L, Prat-Gonz\u00e0lez S, Jord\u00e0 P, S\u00e1nchez J et al (2020) Design of the \u03b23-adrenergic agonist treatment in chronic pulmonary hypertension secondary to heart failure trial. JACC: Basic Translational Sci 5(1):317\u2013327. https:\/\/doi.org\/10.1016\/j.jacbts.2020.01.009","journal-title":"JACC: Basic Translational Sci"},{"key":"1040_CR43","first-page":"687","volume":"290","author":"C Gauthier","year":"1999","unstructured":"Gauthier C, Tavernier G, Trochu JN, Leblais V et al (1999) Interspecies differences in the cardiac negative inotropic effects of \u03b23-adrenoceptor agonists. J Pharmacol Exp Ther 290:687\u2013693","journal-title":"J Pharmacol Exp Ther"},{"key":"1040_CR44","doi-asserted-by":"publisher","unstructured":"Gibbs ME, Hutchinson DS, Summers RJ (2008) Role of beta-adrenoceptors in memory consolidation: beta3-adrenoceptors act on glucose uptake and beta2-adrenoceptors on glycogenolysis. Neuropsychopharmacology. 33(10): 2384-97. https:\/\/doi.org\/10.1038\/sj.npp.1301629. PMID 18046311","DOI":"10.1038\/sj.npp.1301629"},{"issue":"2","key":"1040_CR45","first-page":"264","volume":"44","author":"JG Granneman","year":"1993","unstructured":"Granneman JG, Lahners KN, Chaudhry A (1993) Characterization of the human \u03b23-adrenergic receptor gene. Mol Pharmacol 44(2):264\u2013270. PMID 8102781","journal-title":"Mol Pharmacol"},{"issue":"6","key":"1040_CR46","first-page":"964","volume":"42","author":"JG Granneman","year":"1992","unstructured":"Granneman JG, Lahners KN, Rao DD (1992) \u03b23-adrenergic receptor genes contain an intron within the protein-coding block Rodent and human. Mol Pharmacol 42(6):964\u2013970. PMID 1336117","journal-title":"Mol Pharmacol"},{"issue":"28","key":"1040_CR47","doi-asserted-by":"publisher","first-page":"17686","DOI":"10.1074\/jbc.272.28.17686","volume":"272","author":"D Grujic","year":"1997","unstructured":"Grujic D, Susulic VS, Harper ME, Himms-Hagen J, Cunningham BA, Corkey BE et al (1997) Beta3-adrenergic receptors on white and brown adipocytes mediate beta3-selective agonist-induced effects on energy expenditure, insulin secretion, and food intake. A study using transgenic and gene knockout mice. J Biol Chem 272(28):17686\u201317693. https:\/\/doi.org\/10.1074\/jbc.272.28.17686. PMID 9211919","journal-title":"J Biol Chem"},{"key":"1040_CR48","doi-asserted-by":"publisher","unstructured":"Hadri KE, Courtalon A, Gauthereau X, Chambaut-Gu\u00e9rin AM, Pairault J, F\u00e8ve B (1997) Differential regulation by tumor necrosis factor-alpha of beta1-, beta2- and beta3-adrenoreceptor gene expression in 3T3-F442A adipocytes. J Biol Chem. 272(39): 24514-21. https:\/\/doi.org\/10.1074\/jbc.272.39.24514. PMID 9305915","DOI":"10.1074\/jbc.272.39.24514"},{"key":"1040_CR49","doi-asserted-by":"publisher","unstructured":"Haji E, Al Mahri S, Aloraij Y, Malik SS, Mohammad S (2021) Functional characterization of the obesity-linked variant of the _3-Adrenergic receptor. Int J Mol Sci. 22(11): 5721. https:\/\/doi.org\/10.3390\/ijms22115721. PMID 34072007","DOI":"10.3390\/ijms22115721"},{"key":"1040_CR50","doi-asserted-by":"publisher","unstructured":"Hao L, Scott S, Abbasi M, Zu Y, Khan MSH, Yang Y et al (2019) Beneficial metabolic effects of mirabegron in vitro and in high-fat diet-induced obese mice. J Pharmacol Exp Ther. 369(3): 419\u2009\u2013\u200927. https:\/\/doi.org\/10.1124\/jpet.118.255778. PMID 30940691","DOI":"10.1124\/jpet.118.255778"},{"key":"1040_CR51","doi-asserted-by":"publisher","unstructured":"Hasegawa Y, Ikeda K, Chen Y, Alba DL, Stifler D, Shinoda K et al (2018) Repression of adipose tissue fibrosis through a PRDM16-GTF2IRD1 complex improves systemic glucose homeostasis. Cell Metab. 27(1): 180\u2013194.e6. https:\/\/doi.org\/10.1016\/j.cmet.2017.12.005. PMID 29320702","DOI":"10.1016\/j.cmet.2017.12.005"},{"key":"1040_CR52","doi-asserted-by":"publisher","unstructured":"Hicks A, McCafferty GP, Riedel E, Aiyar N, Pullen M, Evans C et al (2007) GW427353 (solabegron), a novel, selective \u03b23-adrenergic receptor agonist, evokes bladder relaxation and increases micturition reflex threshold in the dog. J Pharmacol Exp Ther. 323(1): 202-9. https:\/\/doi.org\/10.1124\/jpet.107.125757. PMID 17626794","DOI":"10.1124\/jpet.107.125757"},{"key":"1040_CR53","doi-asserted-by":"publisher","unstructured":"Hollenga C, Zaagsma J (1989) \u03b2-adrenoceptors in rat adipocytes\u03b2Direct evidence for the atypical nature of functional. Br J Pharmacol. 98(4): 1420-4. https:\/\/doi.org\/10.1111\/j.1476-5381.1989.tb12692.x. PMID 2575416","DOI":"10.1111\/j.1476-5381.1989.tb12692.x"},{"issue":"5","key":"1040_CR54","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1172\/JCI117936","volume":"95","author":"GS Hotamisligil","year":"1995","unstructured":"Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95(5):2409\u20132415. https:\/\/doi.org\/10.1172\/JCI117936","journal-title":"J Clin Invest"},{"issue":"19","key":"1040_CR55","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1128\/MCB.01034-15","volume":"36","author":"Y Hu","year":"2016","unstructured":"Hu Y, Robichaux WG, Mei FC, Kim ER, Wang H, Tong Q et al (2016) Role of exchange protein directly activated by cyclic AMP isoform 1 in energy homeostasis: regulation of leptin expression and secretion in white adipose tissue. Mol Cell Biol 36(19):2440\u20132450. https:\/\/doi.org\/10.1128\/MCB.01034-15. PMID 27381457","journal-title":"Mol Cell Biol"},{"key":"1040_CR56","doi-asserted-by":"publisher","unstructured":"Igawa Y, Aizawa N, Michel MC (2019) \u03b23-Adrenoceptors in the normal and diseased urinary bladder\u2014what are the open questions? Br J Pharmacol. 176(14): 2525-38. https:\/\/doi.org\/10.1111\/bph.14658. PMID 30868554","DOI":"10.1111\/bph.14658"},{"key":"1040_CR57","doi-asserted-by":"publisher","unstructured":"Jesus \u00cdC, Alle LF, Munhoz EC, Silva LRD, Lopes WA, Tureck LV et al (2018) Trp64Arg polymorphism of the ADRB3 gene associated with maximal fat oxidation and LDL-C levels in non-obese adolescents. J Pediatr (Rio J). 94(4): 425\u2009\u2013\u200931. https:\/\/doi.org\/10.1016\/j.jped.2017.07.010. PMID 28941386","DOI":"10.1016\/j.jped.2017.07.010"},{"issue":"1\u20132","key":"1040_CR58","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/s0167-4889(01)00093-3","volume":"1539","author":"S Klaus","year":"2001","unstructured":"Klaus S, Seivert A, Boeuf S (2001) Effect of beta 3 adrenergic agonist C1316,243 on functional differentiation of with and brown adipocytes in primary cell culture. Biochim Biophys Acta 1539(1\u20132):85\u201392. https:\/\/doi.org\/10.1016\/s0167-4889(01)00093-3. PMID 11389970","journal-title":"Biochim Biophys Acta"},{"key":"1040_CR59","doi-asserted-by":"publisher","unstructured":"Klepac K, Georgiadi A, Tsch\u00f6p M, Herzig S (2019) The role of brown and beige adipose tissue in glycaemic control. Mol Aspects Med. 68: 90\u2013100. https:\/\/doi.org\/10.1016\/j.mam.2019.07.001. PMID 31283940","DOI":"10.1016\/j.mam.2019.07.001"},{"issue":"1","key":"1040_CR60","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1172\/JCI116191","volume":"91","author":"S Krief","year":"1993","unstructured":"Krief S, L\u00f6nnqvist F, Raimbault S, Baude B, Van Spronsen A, Arner P et al (1993) Tissue distribution of \u03b23-adrenergic receptor mRNA in man. J Clin Invest 91(1):344\u2013349. https:\/\/doi.org\/10.1172\/JCI116191. PMID 8380813","journal-title":"J Clin Invest"},{"key":"1040_CR61","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11307-018-1251-6","volume":"21","author":"N Kubo","year":"2019","unstructured":"Kubo N, Kawahara M, Okamatsu-Ogura Y, Miyazaki Y, Otsuka R, Fukuchi K (2019) Evaluation of glucose uptake and uncoupling protein 1 activity in adipose tissue of diabetic mice upon \u03b2-adrenergic stimulation. Mol Imaging Biol 21:249\u2013256","journal-title":"Mol Imaging Biol"},{"issue":"5088","key":"1040_CR62","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/214597a0","volume":"214","author":"AM Lands","year":"1967","unstructured":"Lands AM, Arnold A, McAuliff JP, Luduena FP, Brown TG Jr. (1967) Differentiation of receptor systems activated by sympathomimetic amines. Nature 214(5088):597\u2013598. https:\/\/doi.org\/10.1038\/214597a0. PMID 6036174","journal-title":"Nature"},{"key":"1040_CR63","doi-asserted-by":"publisher","unstructured":"Langin D, Tavernier G, Lafontan M (1995) Regulation of beta 3-adrenoreceptor expression in white fat cells. Fundam Clin Pharmacol. 9(2): 97\u2013106. https:\/\/doi.org\/10.1111\/j.1472-8206.1995.tb00268.x. PMID 7628838","DOI":"10.1111\/j.1472-8206.1995.tb00268.x"},{"issue":"4","key":"1040_CR64","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/ajcn\/76.4.780","volume":"76","author":"TM Larsen","year":"2002","unstructured":"Larsen TM, Toubro S, van Baak MA, Gottesdiener KM, Larson P, Saris WHM, Astrup A (2002) Effect of a 28-d treatment with L-796568, a novel beta(3)-adrenergic receptor agonist, on energy expenditure and body composition in obese men. Am J Clin Nutr 76(4):780\u2013788. https:\/\/doi.org\/10.1093\/ajcn\/76.4.780","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"1040_CR65","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0014-5793(93)81377-c","volume":"324","author":"JM Lelias","year":"1993","unstructured":"Lelias JM, Kaghad M, Rodriguez M, Chalon P, Bonnin J, Dupre I et al (1993) Molecular cloning of a human beta3-adrenegic receptor cDNA. FEBS Lett 324(2):127\u2013130. https:\/\/doi.org\/10.1016\/0014-5793(93)81377-c. PMID 8389717","journal-title":"FEBS Lett"},{"key":"1040_CR66","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1038\/s41598-017-04520-z","volume":"7","author":"B Li","year":"2017","unstructured":"Li B, Qing T, Zhu J, Wen Z, Yu Y, Fukumura R et al (2017) A comprehensive mouse transcriptomic BodyMap across 17 tissues by RNA-seq. Sci Rep 7:4200","journal-title":"Sci Rep"},{"key":"1040_CR67","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/dom.13516","volume":"21","author":"RKC Loh","year":"2019","unstructured":"Loh RKC, Formosa MF, Gerche AL, Reutens AT, Kingwell BA, Carey AL (2019) Acute metabolic and cardiovascular effects of mirabegron in healthy individuals. Diabetes Obes Metab 21:276\u2013284","journal-title":"Diabetes Obes Metab"},{"key":"1040_CR68","doi-asserted-by":"publisher","unstructured":"Lumeng CN, Saltiel AR (2011) Inflammatory links between obesity and metabolic disease. J Clin Invest. 121(6): 2111-7. https:\/\/doi.org\/10.1172\/JCI57132. PMID 21633179","DOI":"10.1172\/JCI57132"},{"key":"1040_CR69","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.3390\/cells9122584","volume":"9","author":"LYM Michel","year":"2020","unstructured":"Michel LYM, Farah C, Balligand J-L (2020) The beta3 adrenergic receptor in healthy and pathological cardiovascular tissues. Cells 9:2584. https:\/\/doi.org\/10.3390\/cells9122584","journal-title":"Cells"},{"key":"1040_CR70","doi-asserted-by":"publisher","unstructured":"Michel MC, Korstanje C (2016) \u03b23-Adrenoceptor agonists for overactive bladder syndrome: role of translational pharmacology in a repositioning clinical drug development project. Pharmacol Ther. 159: 66\u201382. https:\/\/doi.org\/10.1016\/j.pharmthera.2016.01.007. PMID 26808167","DOI":"10.1016\/j.pharmthera.2016.01.007"},{"key":"1040_CR71","doi-asserted-by":"publisher","unstructured":"Min SY, Kady J, Nam M, Rojas-Rodriguez R, Berkenwald A, Kim JH et al (2016) Human \u2019Brite\/beige\u2019 adipocytes develop from capillary networks, and their implantation improves metabolic homeostasis in mice. Nat Med. 22(3): 312-8. https:\/\/doi.org\/10.1038\/nm.4031. PMID 26808348","DOI":"10.1038\/nm.4031"},{"issue":"12","key":"1040_CR72","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1006\/jmcc.2001.1475","volume":"33","author":"S Moniotte","year":"2001","unstructured":"Moniotte S, Vaerman JL, Kockx MM, Larrouy D, Langin D, Noirhomme P, Balligand JL (2001) Real-time RT-PCR for the detection of b-adrenoceptor messenger RNAs in small human endomyocardial biopsies. J Mol Cell Cardiol 33(12):2121\u20132133","journal-title":"J Mol Cell Cardiol"},{"key":"1040_CR73","doi-asserted-by":"crossref","unstructured":"Mowers J, Uhm M, Reilly SM, Simon J, Leto D, Chiang SH et al (2013) Inflammation produces catecholamine resistance in obesity via activation of PDE3B by the protein kinases IKK\u03b5 and TBK1. eLife. 2:e01119 10.7554\/eLife.01119. PMID 24368730","DOI":"10.7554\/eLife.01119"},{"issue":"15","key":"1040_CR74","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1016\/j.molcel.2021.06.024","volume":"81","author":"C Nagiri","year":"2021","unstructured":"Nagiri C, Kobayashi K, Tomita A, Kato M, Kobayashi K et al (2021) Cryo-EM structure of the \u03b23-adrenergic receptor reveals the molecular basis of subtype selectivity. Mol Cell 81(15):3038\u20133040. https:\/\/doi.org\/10.1016\/j.molcel.2021.06.024","journal-title":"Mol Cell"},{"key":"1040_CR75","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1111\/dom.14120","volume":"22","author":"KJ Nahon","year":"2020","unstructured":"Nahon KJ, Janssen LGM, Sardjoe Mishre ASD, Bilsen MP, van der Eijk JA et al (2020) The effect of mirabegron on energy expenditure and brown adipose tissue in healthy lean south Asian and europid men. Diabetes Obes Metab 22:2032\u20132044","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"1040_CR76","first-page":"548","volume":"43","author":"F Nantel","year":"1993","unstructured":"Nantel F, Bonin H, Emorine LJ, Zilberfarb V, Strosberg AD, Bouvier M et al (1993) The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization. Mol Pharmacol 43(4):548\u2013555. PMID 8386307","journal-title":"Mol Pharmacol"},{"key":"1040_CR77","doi-asserted-by":"publisher","unstructured":"Negre\u015f S, Chiri\u0163\u0103 C, Arsene AL, Margin\u0103 D, Moro\u015fan E, Zb\u00e2rcea CE (2017) New potential beta-3 adrenergic agonists with beta-phenylethylamine structure, synthesized for the treatment of dyslipidemia and obesity. https:\/\/doi.org\/10.5772\/65328","DOI":"10.5772\/65328"},{"key":"1040_CR78","doi-asserted-by":"publisher","unstructured":"Nomiya M, Yamaguchi O (2003) A quantitative analysis of mRNA expression of \u03b1 1 and \u03b2-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders. J Urol. 170(2 Pt 1): 649\u2009\u2013\u200953. https:\/\/doi.org\/10.1097\/01.ju.0000067621.62736.7c. PMID 12853849","DOI":"10.1097\/01.ju.0000067621.62736.7c"},{"key":"1040_CR79","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.bbrc.2022.04.065","volume":"611","author":"I Nureki","year":"2022","unstructured":"Nureki I, Kobayashi K, Tanaka T, Demura K, Inoue A, Shihoya W, Nureki O (2022) Cryo-EM structures of the \u03b23 adrenergic receptor bound to solabegron and isoproterenol. Biochem Biophys Res Commun 611:158\u2013164. https:\/\/doi.org\/10.1016\/j.bbrc.2022.04.065","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1040_CR80","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1172\/JCI131126","volume":"130","author":"AE O\u2019Mara","year":"2020","unstructured":"O\u2019Mara AE et al (2020) Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity. J Clin Invest 130(5):2209\u20132219","journal-title":"J Clin Invest"},{"key":"1040_CR81","doi-asserted-by":"publisher","unstructured":"Oana F, Takeda H, Matsuzawa A, Akahane S, Hayashi M, Tamura T et al (2010) KTO-7924, a Beta3-adrenergic receptor agonist, reduces hyperglycemia and protects beta-cells in the islets of Langerhans of db\/db mice. Endocr Res. 35(4): 174\u2009\u2013\u200982. https:\/\/doi.org\/10.3109\/07435800.2010.507733. PMID 20722489","DOI":"10.3109\/07435800.2010.507733"},{"key":"1040_CR82","doi-asserted-by":"crossref","unstructured":"Oana F, Takeda H, Matsuzawa A, Akahane S, Isaji M, Akahane M (2005) Adiponectin receptor 2 expression in liver and insulin resistance in db\/db mice given a beta 3 adrenoreceptor agonist. Eur J Pharmacol. 2005: 71\u2009\u2013\u20096","DOI":"10.1016\/j.ejphar.2005.06.004"},{"issue":"14","key":"1040_CR83","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1111\/bph.14633","volume":"176","author":"K Okeke","year":"2019","unstructured":"Okeke K, Angers S, Bouvier M, Michel MC (2019) Agonist-induced desensitization of \u03b23 -adrenoceptors: where, when, and how? Br J Pharmacol 176(14):2539\u20132558. https:\/\/doi.org\/10.1111\/bph.14633","journal-title":"Br J Pharmacol"},{"issue":"3","key":"1040_CR84","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/luts.12007","volume":"5","author":"A Otsuka","year":"2013","unstructured":"Otsuka A, Kawasaki H, Matsumoto R, Shinbo H, Kurita Y, Iwashita T et al (2013) Expression of \u03b2-adrenoceptor subtypes in urothelium, interstitial cells and detrusor of the human urinary bladder. Low Urin Tract Symptoms 5(3):173\u2013180. https:\/\/doi.org\/10.1111\/luts.12007","journal-title":"Low Urin Tract Symptoms"},{"issue":"4","key":"1040_CR85","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","volume":"98","author":"MC Petersen","year":"2018","unstructured":"Petersen MC, Shulman GI (2018) Mechanisms of insulin action and insulin resistance. Physiol Rev 98(4):2133\u20132223. https:\/\/doi.org\/10.1152\/physrev.00063.2017","journal-title":"Physiol Rev"},{"issue":"11","key":"1040_CR86","doi-asserted-by":"publisher","first-page":"3804","DOI":"10.1128\/MCB.00709-07","volume":"28","author":"RK Petersen","year":"2008","unstructured":"Petersen RK, Madsen L, Pedersen LM, Hallenborg P, Hagland H, Viste K et al (2008) Cyclic AMP (cAMP)-mediated stimulation of adipocyte differentiation requires the synergistic action of Epac- and cAMP-dependent protein kinase-dependent processes. Mol Cell Biol 28(11):3804\u20133816. https:\/\/doi.org\/10.1128\/MCB.00709-07","journal-title":"Mol Cell Biol"},{"issue":"32","key":"1040_CR87","doi-asserted-by":"publisher","first-page":"eadf7119","DOI":"10.1126\/sciadv.adf7119","volume":"9","author":"TCP Pham","year":"2023","unstructured":"Pham TCP, Dollet L, Ali MS, Raun SH, M\u00f8ller LLV, Jafari A et al (2023) TNIK is a conserved regulator of glucose and lipid metabolism in obesity. Sci Adv 9(32):eadf7119. https:\/\/doi.org\/10.1126\/sciadv.adf7119","journal-title":"Sci Adv"},{"issue":"5","key":"1040_CR88","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/ehf2.12306","volume":"5","author":"A-C Pouleur","year":"2018","unstructured":"Pouleur A-C, Anker S, Brito D, Brosteanu O, Hasenclever D, Casadei B et al (2018) Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a \u03b23\u2010adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease \u03b23\u2010left ventricular hypertrophy (Beta3\u2010LVH). ESC Heart Fail 5(5):830\u2013841","journal-title":"ESC Heart Fail"},{"key":"1040_CR89","doi-asserted-by":"publisher","unstructured":"Reilly SM, Chiang SH, Decker SJ, Chang L, Uhm M, Larsen MJ et al (2013) An inhibitor of the protein kinases TBK1 and IKK-\u03b5 improves obesity-related metabolic dysfunctions in mice. Nat Med. 19(3): 313\u2009\u2013\u200921. https:\/\/doi.org\/10.1038\/nm.3082. PMID 23396211","DOI":"10.1038\/nm.3082"},{"issue":"2","key":"1040_CR90","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.eururo.2015.09.007","volume":"69","author":"GM Rosa","year":"2016","unstructured":"Rosa GM, Ferrero S, Nitti VW, Wagg A, Saleem T, Chapple CR (2016) Cardiovascular Safety of \u03b23-adrenoceptor agonists for the treatment of patients with overactive bladder syndrome. Eur Urol 69(2):311\u2013323. https:\/\/doi.org\/10.1016\/j.eururo.2015.09.007","journal-title":"Eur Urol"},{"key":"1040_CR91","doi-asserted-by":"crossref","unstructured":"Rouget C, Rekik M, Camparo P, Botto H, Rischmann P, Lluel P et al (2014) Modulation of nerve-evoked contractions by \u03b23-adrenoceptor agonism in human and rat isolated urinary bladder. Pharmacol Res. 80: 14\u201320. doi: 10.1016\/j.phrs.2013.12.006. PMID 24378642","DOI":"10.1016\/j.phrs.2013.12.006"},{"key":"1040_CR92","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.pharmthera.2005.12.002","volume":"111","author":"B Rozec","year":"2006","unstructured":"Rozec B, Gauthier C (2006) \u00df3-Adrenoceptors in the cardiovascular system: putative roles in human pathologies. Pharmacol Th 111:652\u2013673","journal-title":"Pharmacol Th"},{"issue":"3","key":"1040_CR93","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/jdi.12426","volume":"7","author":"N Sakane","year":"2016","unstructured":"Sakane N, Sato J, Tsushita K, Tsujii S, Kotani K, Tominaga M et al (2016) Effects of lifestyle intervention on weight and metabolic parameters in patients with impaired glucose tolerance related to \u03b2-3 adrenergic receptor gene polymorphism Trp64Arg. J Diabetes Investig 7(3):338\u2013342. https:\/\/doi.org\/10.1111\/jdi.12426","journal-title":"J Diabetes Investig"},{"key":"1040_CR94","doi-asserted-by":"publisher","unstructured":"Saltiel AR, Olefsky JM (2017) Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 127(1): 1\u20134. https:\/\/doi.org\/10.1172\/JCI92035. PMID 28045402","DOI":"10.1172\/JCI92035"},{"issue":"1","key":"1040_CR95","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/27697061.2023.2203235","volume":"43","author":"S Samanta","year":"2024","unstructured":"Samanta S, Chakraborty S, Bagchi D (2024) Pathogenesis of neurodegenerative diseases and the protective role of Natural Bioactive Components. J Am Nutr Assoc 43(1):20\u201332. https:\/\/doi.org\/10.1080\/27697061.2023.2203235","journal-title":"J Am Nutr Assoc"},{"issue":"4","key":"1040_CR96","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3390\/cells8040357","volume":"8","author":"G Schena","year":"2019","unstructured":"Schena G, Caplan MJ (2019) Everything you always wanted to know about \u03b23-AR * (* but were afraid to ask). Cells 8(4):357. https:\/\/doi.org\/10.3390\/cells8040357. PMID 30995798","journal-title":"Cells"},{"issue":"7","key":"1040_CR97","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00210-018-1510-8","volume":"391","author":"D Sellers","year":"2018","unstructured":"Sellers D, Chess-Williams R, Michel MC (2018) Modulation of lower urinary tract smooth muscle contraction and relaxation by the urothelium. Naunyn-Schmiedebergs Arch Pharmacol 391(7):675\u2013694. https:\/\/doi.org\/10.1007\/s00210-018-1510-8","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"2","key":"1040_CR98","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3390\/cells8020178","volume":"19","author":"CH Shin","year":"2019","unstructured":"Shin CH, Choi DS (2019) Essential roles for the non-canonical I\u03baB kinases in linking inflammation to cancer, obesity, and diabetes. Cells 19(2):178. https:\/\/doi.org\/10.3390\/cells8020178. PMID 30791439, PMCID PMC6406369","journal-title":"Cells"},{"issue":"2","key":"1040_CR99","doi-asserted-by":"publisher","first-page":"F388","DOI":"10.1152\/ajprenal.00392.2016","volume":"313","author":"I Silva","year":"2017","unstructured":"Silva I, Costa AF, Moreira S, Ferreirinha F, Magalh\u00e3es-Cardoso MT, Calejo I et al (2017) Inhibition of cholinergic neurotransmission by \u03b23-adrenoceptors depends on adenosine release and \u03b11-receptor activation in human and rat urinary bladders. Am J Physiol Ren Physiol 313(2):F388\u2013403. https:\/\/doi.org\/10.1152\/ajprenal.00392.2016","journal-title":"Am J Physiol Ren Physiol"},{"issue":"9","key":"1040_CR100","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1172\/JCI32519","volume":"118","author":"VA Skeberdis","year":"2008","unstructured":"Skeberdis VA, Gendviliene V, Zablockaite D, Treinys R, Macianskiene R, Bogdelis A, Jurevicius J, Fischmeister R (2008) beta3-adrenergic receptor activation increases human atrial tissue contractility and stimulates the L-type Ca2+ current. J Clin Invest 118(9):3219\u20133227. https:\/\/doi.org\/10.1172\/JCI32519","journal-title":"J Clin Invest"},{"issue":"5","key":"1040_CR101","first-page":"407","volume":"40","author":"VA Skeberdis","year":"2004","unstructured":"Skeberdis VA (2004) Structure and function of b3-adrenergic receptors. Med (Kaunas) 40(5):407\u2013413. PMID 15170407","journal-title":"Med (Kaunas)"},{"issue":"10","key":"1040_CR102","doi-asserted-by":"publisher","first-page":"e7564","DOI":"10.1590\/1414-431X20187564","volume":"51","author":"P Souza-Braga","year":"2018","unstructured":"Souza-Braga P, Lorena FB, Nascimento BPP, Marcelino CP, Ravache TT, Ricci E et al (2018) Adrenergic receptor beta3 is involved in the memory consolidation process in mice. Braz J Med Biol Res 51(10):e7564. https:\/\/doi.org\/10.1590\/1414-431X20187564","journal-title":"Braz J Med Biol Res"},{"key":"1040_CR103","doi-asserted-by":"publisher","unstructured":"Strosberg AD, Pi\u00e9tri-Rouxel F (1996) Function and regulation of the \u03b23-adrenoreceptor. Trends Pharmacol Sci 17(10): 373\u2009\u2013\u200981. https:\/\/doi.org\/10.1016\/s0165-6147(96)80011-3. PMID 8979772.","DOI":"10.1016\/s0165-6147(96)80011-3"},{"key":"1040_CR104","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1146\/annurev.pharmtox.37.1.421","volume":"37","author":"AD Strosberg","year":"1997","unstructured":"Strosberg AD (1997) Structure and function of the beta-3 adrenergic receptor. Annu Rev Pharmacol Toxicol 37:421\u2013450","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1040_CR105","doi-asserted-by":"publisher","unstructured":"Takasu T, Ukai M, Sato S, Matsui T, Nagase I, Maruyama T et al (2007) Effect of (R)-2-(2-aminothiazol-4-yl)-4\u2032-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective \u03b23-adrenoceptor agonist, on bladder function. J Pharmacol Exp Ther. 321(2): 642-7. https:\/\/doi.org\/10.1124\/jpet.106.115840. PMID 17293563","DOI":"10.1124\/jpet.106.115840"},{"issue":"5","key":"1040_CR106","first-page":"409","volume":"7","author":"S Tan","year":"1983","unstructured":"Tan S, Curtis-Prior PB (1983) Characterization of the beta-adrenoreceptor of the adipose cell of the rat. Int J Obes 7(5):409\u2013414. PMID 6139348","journal-title":"Int J Obes"},{"issue":"10","key":"1040_CR107","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.1073\/pnas.89.10.4490","volume":"89","author":"RF Thomas","year":"1992","unstructured":"Thomas RF, Holt BD, Schwinn DA, Liggett SB (1992) Long-term agonist exposure induces up-regulation of \u03b23AR exposure via multiple cAMP response elements. Proc Natl Acad Sci U S A 89(10):4490\u20134494. https:\/\/doi.org\/10.1073\/pnas.89.10.4490. PMID 1374904","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1040_CR108","doi-asserted-by":"publisher","unstructured":"Tournissac M, Vu TM, Vrabic N, Hozer C, Tremblay C, M\u00e9lan\u00e7on K et al (2021) Repurposing beta-3 adrenergic receptor agonists for Alzheimer\u2019s disease: beneficial effects in a mouse model. Alzheimers Res Ther. 13(1): 103. https:\/\/doi.org\/10.1186\/s13195-021-00842-3. PMID 34020681","DOI":"10.1186\/s13195-021-00842-3"},{"key":"1040_CR109","doi-asserted-by":"publisher","unstructured":"Umekawa T, Yoshida T, Sakane N, Saito M, Kumamoto K, Kondo M (1997) Anti-obesity and anti-diabetic effects of CL316,243, a highly specific beta 3-adrenoceptor agonist, in Otsuka Long-Evans Tokushima fatty rats: induction of uncoupling protein and activation of glucose transporter 4 in white fat. Eur J Endocrinol. 136(4): 429\u2009\u2013\u200937. https:\/\/doi.org\/10.1530\/eje.0.1360429. PMID 9150705","DOI":"10.1530\/eje.0.1360429"},{"key":"1040_CR110","doi-asserted-by":"publisher","unstructured":"Valentine JM, Ahmadian M, Keinan O, Abu-Odeh M, Zhao P, Zhou X, Keller MP et al (2022) \u03b23-Adrenergic receptor downregulation leads to adipocyte catecholamine resistance in obesity. J Clin Invest. 132(2): e153357. https:\/\/doi.org\/10.1172\/JCI153357. PMID: 34847077","DOI":"10.1172\/JCI153357"},{"key":"1040_CR111","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1067\/mcp.2002.122527","volume":"71","author":"MA van Baak","year":"2002","unstructured":"van Baak MA, Hul GBJ, Toubro S, Astrup A et al (2002) Acute effect of L-796568, a novel \u03b23-adrenergic receptor agonist, on energy expenditure in obese men. Clin Pharmacol Ther 71:272\u2013279","journal-title":"Clin Pharmacol Ther"},{"key":"1040_CR112","doi-asserted-by":"publisher","unstructured":"Van Spronsen A, Nahmias C, Krief S, Briend-Sutren MM, Strosberg AD, Emorine LJ (1993) The human and mouse \u03b23-adrenergic receptor genes: promoter and intron\/exon structure. Eur J Biochem. 213(3): 1117-24. https:\/\/doi.org\/10.1111\/j.1432-1033.1993.tb17861.x. PMID 8389293","DOI":"10.1111\/j.1432-1033.1993.tb17861.x"},{"issue":"2","key":"1040_CR113","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0378-1119(96)00796-2","volume":"188","author":"J Walston","year":"1997","unstructured":"Walston J, Lowe AL, Silver K, Yang Y, Bodkin NL, Hansen AR et al (1997) \u03b23-adrenergic receptor in the obesity and diabetes prone rhesus monkey is very similar to human and contains\u03b2The arginine at codon 64. Gene 188(2):207\u2013213","journal-title":"Gene"},{"key":"1040_CR114","doi-asserted-by":"publisher","unstructured":"Walston J, Silver K, Bogardus C, Knowler WC, Celi FS, Austin S et al (1995) Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the \u03b23-adrenergic-receptor gene. N Engl J Med. 333(6): 343-7. https:\/\/doi.org\/10.1056\/NEJM199508103330603. PMID 7609750","DOI":"10.1056\/NEJM199508103330603"},{"key":"1040_CR115","doi-asserted-by":"publisher","unstructured":"White CL, Ishihara Y, Dotson TL, Hughes DA, Bray GA, York DA (2004) Effect of beta 3 agonist on food intake in two strains of rats that differ in susceptibility to obesity. Physiol Behav. 82(2\u20133): 489\u2009\u2013\u200996. https:\/\/doi.org\/10.1016\/j.physbeh.2004.04.059. PMID 15276814","DOI":"10.1016\/j.physbeh.2004.04.059"},{"key":"1040_CR116","doi-asserted-by":"publisher","unstructured":"Wu J, Bostr\u00f6m P, Sparks LM, Ye L, Choi JH, Giang AH et al (2012) Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell. 150(2): 366\u2009\u2013\u200976. https:\/\/doi.org\/10.1016\/j.cell.2012.05.016. PMID 22796012","DOI":"10.1016\/j.cell.2012.05.016"},{"key":"1040_CR117","doi-asserted-by":"publisher","unstructured":"Yoshida M, Takeda M, Gotoh M, Nagai S, Kurose T (2018) Vibegron, a novel potent and selective \u03b23-adrenoreceptor agonist, for the treatment of patients with overactive bladder: A randomized, double-blind, placebo-controlled phase 3 study. Eur Urol. 73(5): 783\u2009\u2013\u200990. https:\/\/doi.org\/10.1016\/j.eururo.2017.12.022. PMID 29366513","DOI":"10.1016\/j.eururo.2017.12.022"},{"issue":"7","key":"1040_CR118","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/0024-3205(94)00408-0","volume":"54","author":"T Yoshida","year":"1994","unstructured":"Yoshida T, Sakane N, Wakabayashi Y, Umekawa T, Kondo M (1994) Anti-obesity and anti-diabetic effects of CL 316,243, a highly specific beta 3-adrenoceptor agonist, in yellow KK mice. Life Sci 54(7):491\u2013498. https:\/\/doi.org\/10.1016\/0024-3205(94)00408-0. PMID 8309351","journal-title":"Life Sci"},{"issue":"3","key":"1040_CR119","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3390\/cells9030706","volume":"9","author":"JHM Yung","year":"2020","unstructured":"Yung JHM, Giacca A (2020) Role of c-Jun N-terminal kinase (JNK) in obesity and type 2 diabetes. Cells 9(3):706. https:\/\/doi.org\/10.3390\/cells9030706. PMID 32183037, PMCID PMC7140703","journal-title":"Cells"},{"issue":"10","key":"1040_CR120","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.2337\/diabetes.51.10.2929","volume":"51","author":"HH Zhang","year":"2002","unstructured":"Zhang HH, Halbleib M, Ahmad F, Manganiello VC, Greenberg AS (2002) Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes 51(10):2929\u20132935. https:\/\/doi.org\/10.2337\/diabetes.51.10.2929. PMID 12351429","journal-title":"Diabetes"}],"container-title":["Journal of Physiology and Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-024-01040-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13105-024-01040-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-024-01040-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T04:10:18Z","timestamp":1735359018000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13105-024-01040-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":120,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["1040"],"URL":"https:\/\/doi.org\/10.1007\/s13105-024-01040-z","relation":{},"ISSN":["1138-7548","1877-8755"],"issn-type":[{"value":"1138-7548","type":"print"},{"value":"1877-8755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,15]]},"assertion":[{"value":"19 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}